-
Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第6期
-
Piao Luo1,2，Dandan Liu1，Qian Zhang1，Fan Yang3,4，Yin-Kwan Wong1，Fei Xia1，Junzhe Zhang1，Jiayun Chen1，Ya Tian1，Chuanbin Yang3，Lingyun Dai3，Han-Ming Shen5，Jigang Wang1,2,3,4,6（Artemisinin Research Center，Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences；Central People's Hospital of Zhanjiang；Department of Urology，the Second Clinical Medical College，Jinan University(Shenzhen People's Hospital)；Integrated Chinese and Western Medicine Postdoctoral Research Station，Jinan University；Faculty of Health Sciences，University of Macau；Guangdong Provincial Key Laboratory of New Drug Screening，School of Pharmaceutical Sciences，Southern Medical University）.Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Baoyi Guan1,2，Jinlin Tong1，Haiping Hao3，Zhixu Yang1，Keji Chen1,2，Hao Xu1,2，Anlu Wang1,2（Xiyuan Hospital，China Academy of Chinese Medical Sciences；National Clinical Research Center for Chinese Medicine Cardiology；State Key Laboratory of Natural Medicines，China Pharmaceutical University）.Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Dandan Shen1,2，Bo Wang1,2，Ya Gao1,2，Lijuan Zhao1,2,3，Yaping Bi1,2，Jinge Zhang1,2，Ning Wang4，Huiqin Kang1,2，Jingru Pang1,2，Ying Liu1,2，Luping Pang1,2，Zhe-Sheng Chen5，Yi-Chao Zheng1,2,3，Hong-Min Liu1,2,3（Key Laboratory of Advanced Drug Preparation Technologies，Ministry of Education of China，Collaborative Innovation Center of New Drug Research and Safety Evaluation，Zhengzhou University；Key Laboratory of Henan Province for Drug Quality and Evaluation，Institute of Drug Discovery and Development，School of Pharmaceutical Sciences，Zhengzhou University；State Key Laboratory of Esophageal Cancer Prevention & Treatment，Academy of Medical Sciences，Zhengzhou University；The School of Chinese Medicine，The University of Hong Kong；Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John's University）.Detailed resume of RNA m~6A demethylases[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Chan Feng1,2,3，Yongjiang Li2,4，Bijan Emiliano Ferdows2，Dylan Neal Patel2，Jiang Ouyang2，Zhongmin Tang2，Na Kong2，Enguo Chen1,3，Wei Tao2（Department of Respiratory Medicine，Sir Run Run Shaw Hospital，Zhejiang University School of Medicine；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women's Hospital，Harvard Medical School；Cancer Center，Zhejiang University；Department of Pharmacy，the Second Xiangya Hospital of Central South University；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women’s Hospital，Harvard Medical School）.Emerging vaccine nanotechnology：From defense against infection to sniping cancer[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Xuesong Li1，Ruigong Zhu1，Hong Jiang1，Quanwen Yin1，Jiaming Gu1，Jiajing Chen1，Xian Ji1，Xuan Wu1，Haiping Fu1，Hui Wang1，Xin Tang1，Yuanqing Gao1，Bingjian Wang2，Yong Ji1,3，Hongshan Chen1,3,4,2（Key Laboratory of Cardiovascular and Cerebrovascular Medicine，School of Pharmacy，Nanjing Medical University；Department of Cardiology，Huai'an First People's Hospital Affiliated with Nanjing Medical University；Key Laboratory of Targeted Intervention of Cardiovascular Disease，Collaborative Innovation Center for Cardiovascular Disease Translational Medicine，Nanjing Medical University；Department of Cardiothoracic Surgery，the Second Affiliated Hospital of Nanjing Medical University）.Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Sifan Yu1,2，Dijie Li1,2,3，Ning Zhang4，Shuaijian Ni1,2,3，Meiheng Sun1,2,3，Luyao Wang1,2,3，Huan Xiao4，Dingdong Liu1,2,3，Jin Liu1,2,3，Yuanyuan Yu1,2,3，Zongkang Zhang4，Samuel Tin Yui Yeung1，Shu Zhang5，Aiping Lu1,2,3，Zhenlin Zhang6，Baoting Zhang4，Ge Zhang1,2,3（Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases，School of Chinese Medicine，Hong Kong Baptist University；Institute of Integrated Bioinfomedicine and Translational Science，School of Chinese Medicine，Hong Kong Baptist University；Institute of Precision Medicine and Innovative Drug Discovery，HKBU Institute for Research and Continuing Education；School of Chinese Medicine，Faculty of Medicine，the Chinese University of Hong Kong；The Key Laboratory of Aerospace Medicine，Ministry of Education，Air Force Medical University；Shanghai Clinical Research Center of Bone Disease，Department of Osteoporosis and Bone Diseases，Shanghai Jiao Tong University Affiliated Sixth People's Hospital）.Drug discovery of sclerostin inhibitors[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Yuhong Zhang1，Yanqing Ding1，Min Li1，Jing Yuan2，Youhui Yu2，Xueying Bi1，Huiqi Hong1，Jiantao Ye1，Peiqing Liu1（Department of Pharmacology and Toxicology，School of Pharmaceutical Sciences，National and Local United Engineering Lab of Druggability and New Drugs Evaluation，Sun Yat-sen University；State Key Laboratory of Oncology in Southern China，Collaborative Innovation Center for Cancer Medicine，Sun Yat-sen University Cancer Center）.MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy via targeting ATG4B[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Peihua Liu1，Ling Jiang1，Weimin Kong1，Qiushi Xie1，Ping Li1，Xiaonan Liu1，Jiayi Zhang1，Ming Liu1，Zhongjian Wang2，Liang Zhu1，Hanyu Yang1，Ying Zhou1，Jianjun Zou3，Xiaodong Liu1，Li Liu1（Center of Drug Metabolism and Pharmacokinetics，School of Pharmacy，China Pharmaceutical University；Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy，Xuzhou Medical University；Department of Clinical Pharmacology，Nanjing First Hospital，Nanjing Medical University）.PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α-GLUT2 pathway[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Wufa Fan1，Haixia Peng1，Zhou Yu1，Luting Wang1，Haisheng He1，Yuhua Ma1,2，Jianping Qi1,3，Yi Lu1,3，Wei Wu1,4,3（Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University；Key Laboratory for Tibet Plateau Phytochemistry of Qinghai Province，School of Pharmacy，Qinghai Nationalities University；Shanghai Skin Disease Hospital，Tongji University School of Medicine；Center for Medical Research and Innovation，Shanghai Pudong Hospital，Fudan University Pudong Medical Center）.The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Ting Chen1,2，Bo Zhuang2,3，Yueqi Huang2，Yan Liu2，Bochuan Yuan2，Wanmei Wang2，Tianyu Yuan2，Lina Du1,2，Yiguang Jin1,2（Guangdong Pharmaceutical University；Department of Pharmaceutical Sciences，Beijing Institute of Radiation Medicine；Department of Chemical Defense，Institute of NBC Defense）.Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Xiaoli Pan1，Junping Pei1，Aoxue Wang1，Wen Shuai1，Lu Feng1，Faqian Bu1，Yumeng Zhu1，Lan Zhang2，Guan Wang1，Liang Ouyang1（State Key Laboratory of Biotherapy and Cancer Center，Innovation Center of Nursing Research，Nursing Key Laboratory of Sichuan Province，National Clinical Research Center for Geriatrics，West China Hospital，and Collaborative Innovation Center of Biotherapy，Sichuan University；Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs，School of Life Science and Engineering，Southwest Jiaotong University）.Development of small molecule extracellular signal-regulated kinases（ERKs） inhibitors for cancer therapy[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Qiuyi Li，Cheng Chen，Jinxia Kong，Lian Li，Junlin Li，Yuan Huang（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Lihuan Shang1，Xue Jiang1,2，Ting Yang1，Hongbo Xu1，Qi Xie1，Mei Hu1，Conglian Yang1，Li Kong1，Zhiping Zhang1,3,4（Tongji School of Pharmacy，Huazhong University of Science and Technology；Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Medical Research Center，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；National Engineering Research Center for Nanomedicine，Huazhong University of Science and Technology；Hubei Engineering Research Centre for Novel Drug Delivery System，Huazhong University of Science and Technology）.Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Kun Luo1,2，Wenting Huang1,2，Liansheng Qiao1,2，Xiaoling Zhang3，Di Yan4，Zhiyu Ning1,2，Chengmei Ma3，Honglei Dang3，Dong Wang4，Hongyan Guo3，Lan Xie1,2,3，Jing Cheng1,2,3,4（State Key Laboratory of Membrane Biology，School of Medicine，Tsinghua University；Medical Systems Biology Research Center，School of Medicine，Tsinghua University；National Engineering Research Center for Beijing Biochip Technology；School of Basic Medical Sciences，Chengdu University of Traditional Chinese Medicine）.Dendrocalamus latiflorus and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production via AKT activation[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Xiaoling Chen1，Jingliang Zhang1，KeWei Wang2（Department of Molecular and Cellular Pharmacology，State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；Department of Pharmacology，Qingdao University School of Pharmacy）.Inhibition of intracellular proton-sensitive Ca2+-permeable TRPV3 channels protects against ischemic brain injury[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Hong Tan1，Huali Wang2，Jinhu Ma2，Hui Deng3，Qinghua He4，Qiang Chen2，Qinglian Zhang3（The Research Institute of Qinghai-Tibet Plateau，Southwest Minzu University；State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University，and Collaborative Innovation Center of Biotherapy；School of Laboratory Medicine，Chengdu Medical College；Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization，Southwest Minzu University）.Identification of human LDHC4 as a potential target for anticancer drug discovery[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Zhenlu Xu1，Dongyun Liu2，Dong Liu2，Xue Ren3，Haibo Liu1，Guihong Qi1，Yue Zhou1，Chongming Wu1，Kui Zhu4，Zhongmei Zou1，Jing Yuan3，Wenhan Lin2，Peng Guo1,3（Pharmacology and Toxicology Research Center，Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences，Peking Union Medical College；State Key Laboratory of Natural and Biomimetic Drugs，Peking University；Capital Institute of Pediatrics；National Center for Veterinary Drug Safety Evaluation，College of Veterinary Medicine，China Agricultural University）.Equisetin is an anti-obesity candidate through targeting 11β-HSD1[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Pedro Martín-Acosta1，Qianli Meng1，John Klimek1，Ashok P.Reddy2，Larry David1,3，Stefanie Kaech Petrie3,4，Bingbing X.Li1，Xiangshu Xiao1,3（Program in Chemical Biology，Department of Chemical Physiology and Biochemistry，Oregon Health & Science University；Proteomics Shared Resource，Oregon Health & Science University；Knight Cancer Institute，Oregon Health & Science University；Department of Neurology，Oregon Health & Science University）.A clickable photoaffinity probe of betulinic acid identifies tropomyosin as a target[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Wei Shi1,2,3，Wanzhen Li4，Jianxin Zhang4，Tiehai Li1，Yakai Song1，Yue Zeng1，Qian Dong1，Zeng Lin1，Likun Gong1，Shuquan Fan5，Feng Tang1,2，Wei Huang1,2,3,4（CAS Key Laboratory of Receptor Research，CAS Center for Excellence in Molecular Cell Science，Center for Biotherapeutics Discovery Research，Shanghai Institute of Materia Medica Chinese Academy of Sciences；School of Pharmaceutical Science and Technology，Hangzhou Institute of Advanced Study；University of Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine；School of Life Science，Liaocheng University）.One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Dong Liang，Chen Yu，Zhao Ma，Xingye Yang，Zhenzhen Li，Xuhui Dong，Xiaojun Qin，Lupei Du，Minyong Li（Key Laboratory of Chemical Biology （MOE），School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University）.Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Nazi Song1，Hongjiao Xu1，Jiahua Liu2,3,4，Qian Zhao1，Hui Chen1，Zhibin Yan5,6，Runling Yang5,6，Zhiteng Luo1，Qi Liu7，Jianmei Ouyang7，Shuohan Wu1，Suijia Luo7，Shuyin Ye7，Runfeng Lin1，Xi Sun2,3,4，Junqiu Xie5,6，Tian Lan8，Zhongdao Wu2,3,4，Rui Wang5,6，Xianxing Jiang1（School of Pharmaceutical Sciences，Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery，Sun Yat-sen University；Department of Parasitology of Zhongshan School of Medicine，Sun Yat-sen University；Key Laboratory of Tropical Disease Control，Ministry of Education，Sun Yat-sen University；Provincial Engineering Technology Research Center for Biological Vector Control，Sun Yat-sen University；Research Unit of Peptide Science，Chinese Academy of Medical Sciences；Key Laboratory of Preclinical Study for New Drugs of Gansu Province，School of Basic Medical Sciences，Lanzhou University；Shenzhen Turier Biotech.Co.，Ltd.；Guangdong Pharmaceutical University）.Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Siping Liang1，Jiaying Li2，Zhengyu Zou1，Miao Mao3，Siqi Ming1，Fan Lin3，Ziyan Zhang3，Can Cao1，Jinyu Zhou1，Yuanqing Zhang3，Jiaping Li4，Minhao Wu1（Zhongshan School of Medicine，Sun Yat-sen University；Department of Laboratory Medicine，Guangdong Second Provincial General Hospital；Guangdong Key Laboratory of Chiral Molecule and Drug Discovery，School of Pharmaceutical Sciences，Sun Yatsen University；Department of Interventional Oncology，The First Affiliated Hospital，Sun Yat-sen University）.Tetrahedral DNA nanostructures synergize with MnO2 to enhance antitumor immunity via promoting STING activation and M1 polarization[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Weiyi Xia1，Chao Li2，Qinjun Chen2，Jiancheng Huang1，Zhenhao Zhao2，Peixin Liu2，Kai Xu1，Lei Li1，Fangyuan Hu1，Shujie Zhang1，Tao Sun2，Chen Jiang2，Chen Zhao1（Department of Ophthalmology and Vision Science，Eye & ENT Hospital，Shanghai Medical School，Fudan University；Key Laboratory of Smart Drug Delivery，Ministry of Education，Department of Pharmaceutics，School of Pharmacy，Fudan University）.Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Wei Gao1，Hongxiang Hu1，Lipeng Dai1，Miao He1，Hebao Yuan1，Huixia Zhang1，Jinhui Liao1，Bo Wen1，Yan Li2，Maria Palmisano2，Mohamed Dit Mady Traore1，Simon Zhou2，Duxin Sun1（Department of Pharmaceutical Sciences，College of Pharmacy，University of Michigan；Translational Development and Clinical Pharmacology，Bristol Myers Squibb）.Structure-tissue exposure/selectivity relationship（STR） correlates with clinical efficacy/safety[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Di Zhu1,2，Yu Lu1,2，Lin Gui1,2，Wenjing Wang3，Xi Hu4，Su Chen5，Yanming Wang6，Yuji Wang1,2（Department of Medicinal Chemistry，College of Pharmaceutical Sciences of Capital Medical University；Beijing Area Major Laboratory of Peptide and Small Molecular Drugs，Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China，Beijing Laboratory of Biomedical Materials；Beijing Institute of Hepatology，Beijing Youan Hospital，Capital Medical University；Quantum Design China Ltd.，Universal Business Park；Laboratory of Biomaterials and Biomechanics，Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction，School of Stomatology，Capital Medical University；School of Life Sciences，Henan University）.Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Zhuo-Xun Wu1，Qiu-Xu Teng1，Yuqi Yang1，Nikita Acharekar1，Jing-Quan Wang1，Min He2，Sabesan Yoganathan1，Jun Lin3，Jian Wang2，Zhe-Sheng Chen1（Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John's University；Department of Radiotherapy，the Affiliated Jiangyin People's Hospital of Nantong University；Department of Anesthesiology，Stony Brook University Health Sciences Center）.MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter：In vitro and in vivo study[J].Acta Pharmaceutica Sinica B,2022,第5期
-
Jie Chang1,2，Ruirui Yang2,3,4，Lifan Chen2,3，Zisheng Fan1,2，Jingyi Zhou1,2，Hao Guo2,3，Yinghui Zhang2,3，Yadan Liu1,2，Guizhen Zhou1,2，Keke Zhang1,2，Kaixian Chen2,3,1，Hualiang Jiang2,3,1,4，Mingyue Zheng2,3,1，Sulin Zhang2,3（School of Chinese Materia Medica，Nanjing University of Chinese Medicine；Drug Discovery and Design Center，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Shanghai Institute for Advanced Immunochemical Studies，and School of Life Science and Technology，ShanghaiTech University）.Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer[J].Acta Pharmaceutica Sinica B,2022,第5期
|